Novobiocin Susceptibility Test for Staphylococcus saprophyticus Identification

The novobiocin susceptibility test is a standardized disk diffusion method used to differentiate Staphylococcus saprophyticus from other coagulase-negative staphylococci (CoNS) based on its intrinsic resistance to novobiocin. This test is most useful when a Gram-positive, catalase-positive, coagulase-negative coccus is isolated from a urine specimen from a young, sexually active female outpatient, as S. saprophyticus is a common cause of uncomplicated urinary tract infections in this population. A zone of inhibition ≤16 mm around a 5-μg novobiocin disk after 16–18 hours of incubation at 35±2°C indicates resistance, consistent with S. saprophyticus, while a zone ≥17 mm indicates susceptibility, typical of other CoNS such as Staphylococcus epidermidis and Staphylococcus hominis.

At a Glance

Scientific Principle

The novobiocin susceptibility test exploits a species-specific difference in susceptibility to the aminocoumarin antibiotic novobiocin. Novobiocin inhibits bacterial DNA gyrase (topoisomerase II) by binding to the ATP-binding pocket of the GyrB subunit, thereby blocking DNA supercoiling and replication. Staphylococcus saprophyticus possesses an intrinsic resistance mechanism, primarily mediated by a naturally occurring mutation in the gyrB gene that reduces novobiocin binding affinity. This resistance is a stable, species-level characteristic that distinguishes S. saprophyticus from most other clinically relevant CoNS species, which are typically susceptible to novobiocin [1].

The disk diffusion method measures the inhibition of bacterial growth around a paper disk impregnated with a standardized concentration of novobiocin (5 μg). As the antibiotic diffuses radially into the agar, a concentration gradient is established. Susceptible organisms are inhibited at a greater distance from the disk, producing a larger zone of inhibition, while resistant organisms grow closer to the disk, producing a smaller or absent zone. The zone diameter is measured and compared to established breakpoints to categorize the isolate as resistant or susceptible.

This test is a cornerstone of the preliminary identification scheme for CoNS, particularly when the clinical context suggests S. saprophyticus. It is important to note that novobiocin resistance is not exclusive to S. saprophyticus; other staphylococcal species, such as Staphylococcus cohnii and Staphylococcus xylosus, may also demonstrate resistance. Therefore, the novobiocin test is used in conjunction with other phenotypic tests (e.g., coagulase, urease, and pyrrolidonyl arylamidase activity) for definitive identification [1][3].

Materials and Instrumentation

Novobiocin Disks

Commercially prepared disks containing 5 μg of novobiocin are the standard. Disks must be stored in a sealed, desiccated container at 2–8°C. Allow disks to reach room temperature (20–25°C) for approximately 30 minutes before opening the container to prevent condensation. Never use disks beyond their expiration date. Each disk cartridge should be inspected for discoloration, crumbling, or other signs of deterioration before use.

Mueller-Hinton Agar

Mueller-Hinton agar (MHA) is the recommended medium for disk diffusion testing according to Clinical and Laboratory Standards Institute (CLSI) guidelines. The agar depth should be 4 mm (approximately 25 mL in a 100-mm plate). Plates should be stored at 2–8°C and used within 7 days of preparation. Before inoculation, check that the agar surface is dry; if moisture is present, pre-incubate plates (lid slightly ajar) at 35°C for 10–15 minutes. The pH of each lot should be between 7.2 and 7.4 at room temperature.

Inoculum Preparation

• Sterile saline (0.85% NaCl) or sterile broth (e.g., tryptic soy broth)
• Sterile cotton swabs
• 0.5 McFarland turbidity standard (commercial or freshly prepared)
• Vortex mixer
• Sterile test tubes

Incubation Equipment

• Incubator set to 35±2°C, ambient air
• Timer or log for recording incubation start and end times

Measurement Tools

• Caliper or ruler with millimeter markings
• Adequate lighting (e.g., a colony counter with a magnifying lens)
• Reflected light for reading zones

Quality Control Strains

• Staphylococcus saprophyticus ATCC 15305 (novobiocin-resistant; expected zone ≤16 mm)
• Staphylococcus epidermidis ATCC 12228 (novobiocin-susceptible; expected zone ≥17 mm)

These strains should be maintained according to standard microbiological practices. Working cultures can be kept on tryptic soy agar slants at 2–8°C for up to one week. For long-term storage, use cryopreservation at -70°C or lyophilization.

Controls

Positive Control (Resistant)

Staphylococcus saprophyticus ATCC 15305 should consistently produce a zone of inhibition ≤16 mm. If this strain yields a zone ≥17 mm, the test system is compromised (e.g., expired disk, contaminated medium, or incorrect inoculum).

Negative Control (Susceptible)

Staphylococcus epidermidis ATCC 12228 should consistently produce a zone of inhibition ≥17 mm. If this strain yields a zone ≤16 mm, the test system is compromised.

Medium Control

An uninoculated MHA plate should be incubated alongside the test to verify sterility. No growth should be observed.

Disk Potency Control

Each new lot of novobiocin disks should be tested with the quality control strains before routine use. Record the zone diameters and verify they fall within the expected ranges.

Incubation Conditions Control

Monitor and record the incubator temperature daily. The temperature must remain within 35±2°C throughout the incubation period.

Conceptual Workflow

Step 1: Isolate Preparation

Obtain a pure culture of the CoNS isolate to be tested. The isolate should be 18–24 hours old when tested. Subculture the isolate onto a non-selective agar (e.g., tryptic soy agar or blood agar) and incubate at 35±2°C for 18–24 hours.

Step 2: Inoculum Standardization

Using a sterile loop or swab, transfer 3–5 morphologically similar colonies from the pure culture into 2–3 mL of sterile saline or broth. Vortex thoroughly to create a homogeneous suspension. Adjust the turbidity to match a 0.5 McFarland standard. This corresponds to approximately 1.5 × 10⁸ CFU/mL. If the suspension is too turbid, add more diluent; if too light, add more colonies. Use a vortex mixer to ensure uniformity.

Step 3: Inoculation of MHA Plate

Within 15 minutes of adjusting the inoculum, dip a sterile cotton swab into the suspension. Rotate the swab against the inside wall of the tube above the liquid level to remove excess fluid. Streak the swab evenly over the entire surface of the MHA plate in three directions (e.g., horizontal, vertical, and diagonal) to ensure confluent growth. Rotate the plate approximately 60 degrees between each streaking direction. Allow the plate surface to dry for 3–5 minutes (no more than 15 minutes) before applying disks.

Step 4: Disk Application

Using sterile forceps or a disk dispenser, apply a 5-μg novobiocin disk to the inoculated agar surface. Gently press the disk down with the forceps tip to ensure complete contact with the agar. Once applied, the disk should not be moved. Place the disk at least 15 mm from the edge of the plate and at least 24 mm from the center of any other disk if multiple disks are used on the same plate. For a single novobiocin test, the disk can be placed in the center of the plate.

Step 5: Incubation

Invert the plate and incubate at 35±2°C in ambient air for 16–18 hours. Do not stack plates more than five high to ensure uniform temperature and air circulation. Record the incubation start and end times.

Step 6: Zone Measurement

After incubation, examine the plate for a zone of inhibition around the novobiocin disk. Measure the diameter of the zone (including the disk) to the nearest millimeter using a caliper or ruler. Hold the ruler on the back of the plate (inverted) with reflected light. For accurate measurement, the zone edge should be read at the point where there is a sharp decline in growth density. If the zone contains discrete colonies (i.e., not confluent growth), measure the diameter of the clear zone, ignoring the isolated colonies.

Step 7: Interpretation

Compare the measured zone diameter to the interpretive criteria:

• Resistant (R): Zone diameter ≤16 mm. This result is consistent with S. saprophyticus.
• Susceptible (S): Zone diameter ≥17 mm. This result is consistent with other CoNS (e.g., S. epidermidis, S. hominis).

Record the result as "Novobiocin-resistant" or "Novobiocin-susceptible."

Quality Checks

Pre-Analytical

• Verify the expiration date and storage conditions of novobiocin disks.
• Confirm the MHA plate is within its expiration date and free of contamination or excessive moisture.
• Ensure the 0.5 McFarland standard is properly prepared and used within 6 months of preparation if stored in the dark at room temperature.
• Check that the incubator temperature is within range (35±2°C) before starting the test.

Analytical

• Perform quality control testing with ATCC strains on each day of testing or at least weekly if the test is performed regularly.
• Verify that the inoculum is correctly standardized. A properly standardized inoculum should produce semi-confluent growth (not too heavy or too light).
• Ensure the disk is firmly in contact with the agar surface. A disk that lifts off the agar will produce an inaccurate zone.

Post-Analytical

• Measure zones accurately. If the zone edge is indistinct, use the point where growth is reduced by approximately 80% compared to the lawn.
• Record all results in a laboratory notebook or electronic system, including the date, isolate identifier, zone diameter, and interpretation.
• If quality control results are out of range, do not report patient results. Investigate the cause (e.g., expired disk, contaminated medium, incorrect inoculum) and repeat the test.

Result Interpretation

Resistant (≤16 mm)

A zone diameter of 16 mm or less indicates novobiocin resistance. This result is consistent with Staphylococcus saprophyticus and supports its identification when combined with other phenotypic characteristics (coagulase-negative, catalase-positive, Gram-positive cocci in clusters). However, as noted, other CoNS species (e.g., S. cohnii, S. xylosus) can also be novobiocin-resistant. Therefore, the novobiocin test is a presumptive identification tool and should be confirmed by additional tests (e.g., urease production, pyrrolidonyl arylamidase activity, or commercial identification systems) when species-level identification is required for clinical management [1][4].

Susceptible (≥17 mm)

A zone diameter of 17 mm or greater indicates novobiocin susceptibility. This result is typical of most CoNS species, including S. epidermidis, S. hominis, S. haemolyticus, and S. warneri. A susceptible result effectively rules out S. saprophyticus as the identification.

Borderline Results

Zone diameters exactly at the breakpoint (16 mm or 17 mm) should be interpreted with caution. Repeat the test with a fresh inoculum and a new disk. If the result remains borderline, consider using an alternative identification method (e.g., MALDI-TOF MS or 16S rRNA gene sequencing) [1][3].

Reporting

Report the result as "Novobiocin-resistant" or "Novobiocin-susceptible." Do not report a "sensitive" or "intermediate" category for this test, as CLSI breakpoints only define resistant and susceptible categories for novobiocin in staphylococci.

Troubleshooting

Limitations

Species Specificity

Novobiocin resistance is not unique to S. saprophyticus. Other CoNS species, including S. cohnii, S. xylosus, S. sciuri, and S. lentus, can also be novobiocin-resistant. Therefore, a resistant result is presumptive and must be interpreted in the context of the clinical specimen source and other phenotypic tests [1][3].

Clinical Context

The novobiocin test is most useful for urine isolates from young, sexually active females with community-acquired UTIs. Its utility is limited for isolates from other sources (e.g., blood, wounds) where other CoNS species are more common.

Not a Substitute for Definitive Identification

The novobiocin test is a screening tool. For definitive species-level identification, especially in cases where the result is unexpected or clinically critical, confirmatory methods such as MALDI-TOF MS, 16S rRNA gene sequencing, or commercial biochemical panels should be used [1][3].

Disk Diffusion Limitations

The disk diffusion method is a qualitative or semi-quantitative test. It does not provide a minimum inhibitory concentration (MIC). For MIC determination, broth microdilution or agar dilution methods are required.

Medium and Incubation Conditions

The test is standardized for MHA incubated at 35±2°C for 16–18 hours. Deviations from these conditions (e.g., using blood agar, different incubation temperatures, or extended incubation) may alter zone diameters and invalidate the interpretive criteria.

Quality Control Requirements

The test requires daily or weekly quality control with reference strains. Laboratories that perform the test infrequently may find it challenging to maintain QC cultures.

Documentation

Laboratory Records

Maintain the following records for each test:

• Date and time of test initiation and reading
• Isolate identifier (e.g., accession number, patient ID)
• Source of isolate (e.g., urine, wound)
• Novobiocin disk lot number and expiration date
• MHA lot number and expiration date
• Incubator temperature at start and end of incubation
• Zone diameter (in mm)
• Interpretation (resistant or susceptible)
• QC results for the day (zone diameters for ATCC 15305 and ATCC 12228)
• Any deviations from the standard protocol and corrective actions taken

Reporting

Report the result to the requesting clinician or laboratory information system. Include the isolate identification (e.g., "CoNS, novobiocin-resistant, consistent with S. saprophyticus") and the zone diameter. If the result is used for presumptive identification, note that confirmatory testing may be required.

Archiving

Retain all records for at least the period specified by local regulations or laboratory accreditation requirements (typically 2–5 years). Store QC records and disk lot verification data for the life of the product.

Biosafety

Risk Assessment

Staphylococcus saprophyticus is classified as a Biosafety Level 1 (BSL-1) agent. It is an opportunistic pathogen that rarely causes disease in healthy individuals beyond uncomplicated UTIs. Standard microbiological practices are sufficient for handling this organism in a teaching or diagnostic laboratory [6].

Personal Protective Equipment (PPE)

• Wear a laboratory coat or gown.
• Wear disposable gloves when handling cultures and disks.
• Wear safety glasses if there is a risk of splashes.

Work Practices

• Perform all manipulations of cultures in a biological safety cabinet (BSC) if aerosols are likely (e.g., vortexing, opening culture tubes). For routine disk diffusion testing on solid media, a BSC is not strictly required but is recommended if available.
• Decontaminate work surfaces before and after each procedure with an appropriate disinfectant (e.g., 10% bleach solution or 70% ethanol).
• Dispose of all contaminated materials (plates, swabs, gloves) in biohazard waste containers.
• Wash hands thoroughly after removing gloves and before leaving the laboratory.

Spill Management

• Cover the spill with absorbent material (e.g., paper towels).
• Apply disinfectant (e.g., 10% bleach) and allow 20 minutes of contact time.
• Clean up the spill using fresh absorbent material and dispose of it in biohazard waste.
• Decontaminate the area again with disinfectant.

Training

All personnel performing the novobiocin test must receive training in BSL-1 practices, including proper hand hygiene, waste disposal, and spill cleanup. Training should be documented and refreshed annually [6][7].

Frequently Asked Questions

1. Can the novobiocin test be performed directly on a urine specimen?

No. The novobiocin test requires a pure culture of the isolate. Direct testing on a urine specimen would be unreliable because the specimen may contain multiple bacterial species or a mixed population of staphylococci. The isolate must first be subcultured to obtain a pure, 18–24-hour-old culture.

2. What should I do if my quality control strain gives an unexpected result?

First, verify that you used the correct ATCC strain and that it was properly subcultured. Check the expiration date and storage conditions of the novobiocin disk and MHA plate. Repeat the test with fresh reagents. If the problem persists, contact the manufacturer of the disk or medium. Do not report patient results until QC is within range.

3. Is the novobiocin test sufficient for definitive identification of S. saprophyticus?

No. The novobiocin test is a presumptive identification tool. A novobiocin-resistant CoNS isolate from urine is highly suggestive of S. saprophyticus, but definitive identification requires additional tests (e.g., urease production, pyrrolidonyl arylamidase activity, or commercial identification systems) or molecular methods (e.g., MALDI-TOF MS or 16S rRNA gene sequencing) [1][3].

4. Can I use a 30-μg novobiocin disk instead of the 5-μg disk?

No. The interpretive criteria (≤16 mm for resistant, ≥17 mm for susceptible) are standardized for the 5-μg disk. Using a different disk content will produce different zone diameters and invalidate the interpretation. Always use the 5-μg novobiocin disk for this test.

References and Further Reading

1. Characteristics of Staphylococcus saprophyticus Isolated from Humans and Animals – Provides epidemiological and antimicrobial susceptibility data for S. saprophyticus, including novobiocin resistance patterns.
2. Antimicrobial Potential of Probiotic Strains Against Staphylococcus saprophyticus – Describes antibiotic susceptibility testing of S. saprophyticus clinical isolates using the disk diffusion method.
3. Staphylococcus caseorum sp. nov., a New Species from Spanish Cheese – Includes novobiocin resistance testing as part of phenotypic characterization of novel staphylococcal species.
4. Surveillance on Antimicrobial Resistance at a Ghanaian Healthcare Facility – Reports isolation of multidrug-resistant S. saprophyticus from hospital surfaces, demonstrating the clinical relevance of this species.
5. Investigation of Bacterial Infections and Antibiotic Resistance Patterns in Iran – Provides context for antimicrobial susceptibility testing of staphylococci in clinical settings.
6. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition – Authoritative guidelines for biosafety practices in microbiological laboratories.
7. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules – Framework for biosafety in research settings.
8. NCBI Bookshelf: Molecular Biology and Laboratory Methods – Searchable collection of authoritative methods references for molecular biology and microbiology.

Related Articles

• How to Perform a Novobiocin Susceptibility Test: Principle and Protocol
• Optochin Susceptibility Test for Streptococcus pneumoniae Identification
• Bacitracin Susceptibility Test for Group A Streptococcus Identification
• Coagulase Test: Slide and Tube Methods for Staphylococcus Identification
• How to Perform an Optochin Susceptibility Test: Principle and Protocol
• How to Perform a Bacitracin Susceptibility Test: Principle and Protocol